Equity · Healthcare
MIRM
Mirum Pharmaceuticals, Inc. · NasdaqGM
The line runs $99 on 22 May through $118.69 on 17 July, on a scale from $90 to $130. Days the market did not trade hold the previous close, flat.
The chart above plots the price of MIRM over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 38 sessions over that window: $99 on 22 May 2026 through $118.69 on 17 July 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 20, 2026
MIRM insider trades
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
MIRM reported financials
MIRM reported revenue of $521.3M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$23.4M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
MIRM earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
MIRM institutional holders
9 of the 45 institutional funds we track reported a MIRM position for the quarter ended 30 Jun 2026 — a combined $273.9M; the latest of those filings landed 14 Aug 2026.
Source: SEC EDGAR 13F filings
MIRM fails-to-deliver
On 31 Jul 2026, 72 shares of MIRM failed to deliver (about $8K).
Source: SEC fails-to-deliver (CNS) data